Cardiogenic small molecules that enhance myocardial repair by stem cells
- 22 April 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (16), 6063-6068
- https://doi.org/10.1073/pnas.0711507105
Abstract
The clinical success of stem cell therapy for myocardial repair hinges on a better understanding of cardiac fate mechanisms. We have identified small molecules involved in cardiac fate by screening a chemical library for activators of the signature gene Nkx2.5, using a luciferase knockin bacterial artificial chromosome (BAC) in mouse P19CL6 pluripotent stem cells. We describe a family of sulfonyl-hydrazone (Shz) small molecules that can trigger cardiac mRNA and protein expression in a variety of embryonic and adult stem/progenitor cells, including human mobilized peripheral blood mononuclear cells (M-PBMCs). Small-molecule-enhanced M-PBMCs engrafted into the rat heart in proximity to an experimental injury improved cardiac function better than control cells. Recovery of cardiac function correlated with persistence of viable human cells, expressing human-specific cardiac mRNAs and proteins. Shz small molecules are promising starting points for drugs to promote myocardial repair/regeneration by activating cardiac differentiation in M-PBMCs.Keywords
This publication has 21 references indexed in Scilit:
- Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism?Heart, 2008
- A Common Progenitor at the Heart of DevelopmentCell, 2006
- Developmental Origin of a Bipotential Myocardial and Smooth Muscle Cell Precursor in the Mammalian HeartCell, 2006
- Multipotent Embryonic Isl1+ Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell DiversificationCell, 2006
- Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapyProceedings of the National Academy of Sciences of the United States of America, 2006
- The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesisGenes & Development, 2006
- Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiationNature Medicine, 2004
- Small Molecules that Induce Cardiomyogenesis in Embryonic Stem CellsJournal of the American Chemical Society, 2004
- Fibroblast Growth Factor Receptor-1 Is Essential for In Vitro Cardiomyocyte DevelopmentCirculation Research, 2003
- Differentiation of Beating Cardiac Muscle Cells from a Derivative of P19 Embryonal Carcinoma Cells.Cell Structure and Function, 1996